Cargando…

COVID-19 Vaccines against Omicron Variant: Real-World Data on Effectiveness

The efficacy of vaccines against coronavirus disease 2019 (COVID-19) has now been well established in phase III clinical trials. However, clinical studies based on real-world data remain critical to assess vaccines effectiveness (VE), especially in specific populations and against variants of concer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kherabi, Yousra, Launay, Odile, Luong Nguyen, Liem Binh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611744/ https://www.ncbi.nlm.nih.gov/pubmed/36298641 http://dx.doi.org/10.3390/v14102086

Ejemplares similares

Re: ‘clinical characteristics of ambulatory and hospitalised patients with monkeypox virus infection’ by Mailhe et al.
por: Kherabi, Yousra, et al.
Publicado: (2023)

Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review
por: Galmiche, Simon, et al.
Publicado: (2022)

Vaccine effectiveness against COVID-19 hospitalization in adults in France: A test negative case control study
por: Luong Nguyen, Liem Binh, et al.
Publicado: (2022)

COVID-19 vaccines: A race against time
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

A national platform for Covid-19 vaccine studies recruitment in France: Covireivac volunteer’s characteristics
por: Bonneton, Marion, et al.
Publicado: (2022)

Estimation of Real-World Vaccination Effectiveness of mRNA COVID-19 Vaccines against Delta and Omicron Variants in Japan
por: Kodera, Sachiko, et al.
Publicado: (2022)

Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
por: Fiolet, Thibault, et al.
Publicado: (2022)

Real-World COVID-19 Vaccine Protection Rates against Infection in the Delta and Omicron Eras
por: Zhu, Yuru, et al.
Publicado: (2023)

Efficacy of COVID-19 vaccines: From clinical trials to real life
por: Deplanque, Dominique, et al.
Publicado: (2021)

Vaccins COVID-19 : une course contre la montre
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

Real-world effectiveness of mRNA COVID-19 vaccines in the elderly during the Delta and Omicron variants: Systematic review
por: Palalay, Harvey, et al.
Publicado: (2023)

Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
por: Lau, Jonathan J., et al.
Publicado: (2023)

COVID-19 vaccine boosters: What do we know so far?
por: Kherabi, Yousra, et al.
Publicado: (2021)

Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant
por: Higdon, Melissa M, et al.
Publicado: (2022)

Dose de rappel du vaccin COVID-19 : que savons-nous à ce jour ?
por: Kherabi, Yousra, et al.
Publicado: (2022)

Using survey data to estimate the impact of the omicron variant on vaccine efficacy against COVID-19 infection
por: Rufino, Jesús, et al.
Publicado: (2023)

Omicron variant and booster COVID-19 vaccines
por: Burki, Talha Khan
Publicado: (2022)

COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England
por: Kirsebom, Freja C M, et al.
Publicado: (2022)

COVID-19 : les thérapeutiques
por: KHERABI, Yousra, et al.
Publicado: (2022)

Real-world experience of arbidol for Omicron variant of SARS-CoV-2
por: Zhao, Jingya, et al.
Publicado: (2023)

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
por: Andrews, Nick, et al.
Publicado: (2022)

Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant
por: Khan, Kanwal, et al.
Publicado: (2022)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
por: Zang, Jinkai, et al.
Publicado: (2022)

Lyapunov stability and wave analysis of Covid-19 omicron variant of real data with fractional operator
por: Xu, Changjin, et al.
Publicado: (2022)

Publisher Correction: Using survey data to estimate the impact of the omicron variant on vaccine efficacy against COVID‑19 infection
por: Rufino, Jesús, et al.
Publicado: (2023)

A Systematic Review and Meta-Analysis on the Real-World Effectiveness of COVID-19 Vaccines against Infection, Symptomatic and Severe COVID-19 Disease Caused by the Omicron Variant (B.1.1.529)
por: Mohammed, Hassen, et al.
Publicado: (2023)

COVID vaccine booster doses for omicron variants
por: Burki, Talha
Publicado: (2022)

Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization
por: Feikin, Daniel R., et al.
Publicado: (2022)

Real-World Utilization of Molnupiravir during the COVID-19 Omicron Surge in Israel
por: Weil, Clara, et al.
Publicado: (2023)

Changes in COVID-19 CT Manifestations with Vaccination and the Omicron Variant
por: Yoon, Soon Ho, et al.
Publicado: (2023)

Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants
por: Zhang, Yuntao, et al.
Publicado: (2022)

Real-world effectiveness of nirmatrelvir–ritonavir against BA.4 and BA.5 omicron SARS-CoV-2 variants
por: Wong, Carlos K H, et al.
Publicado: (2023)

mRNA vaccine effectiveness against hospitalisation due to severe acute respiratory infection (SARI) COVID-19 during Omicron variant predominance estimated from real-world surveillance data, Slovenia, February to March 2022
por: Grgič Vitek, Marta, et al.
Publicado: (2022)

World Facing the latest variant of Concern---------Omicron
por: Javaid, Muhammad Mohsin, et al.
Publicado: (2022)

Real-world evaluation of bebtelovimab effectiveness during the period of COVID-19 Omicron variants, including BA.4/BA.5
por: Molina, Kyle C., et al.
Publicado: (2023)

Real-world clinical effectiveness of Tixagevimab/Cilgavimab and Regdanvimab monoclonal antibodies for COVID-19 treatment in Omicron variant-dominant period
por: Fomina, Daria S., et al.
Publicado: (2023)

COVID-19 Vaccine Effectiveness against Omicron Variant among Underage Subjects: The Veneto Region’s Experience
por: Cocchio, Silvia, et al.
Publicado: (2022)

Boosting with variant-matched vaccines: an opportunity to win the race against Omicron
por: Wang, Jiayu, et al.
Publicado: (2022)

Protective Effect of Inactivated COVID-19 Vaccines against Omicron BA.2 Infection in Guangzhou: A Test-Negative Case-Control Real-World Study
por: Zhang, Dingmei, et al.
Publicado: (2023)

Does the homologous booster with the inactivated coronavirus disease 2019 vaccine work for the omicron variant? Real-world evidence from Jilin, China
por: Guo, Jun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_73scboqc8666gebqitr6n6ik9r